Michal Ruprecht
- Indexed articles, last 90 days
- 1
- Latest publication
- Aug 13, 2026
- Outlet visibility, for Jefferson Public Radio
- Top 5M sites
- Earliest in this view
- Aug 13, 2026
Latest articles
The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews (opens the original)
Read excerpt
Kalisizo, Uganda — Along the deeply rutted red dirt roads of central Uganda's Lake Victoria coast, there is little for miles beyond banana groves and bustling markets. The landscape is unassuming — and very dusty. Yet few places have done more to shape HIV care. Irene knows this well. For the past three years, the soft-spoken 22-year-old, who is HIV-negative, has been a participant in one of the most influential HIV clinical trials. She asked NPR to only use her first name for fear of discrimina
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Jefferson Public Radio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.